SCP Private Credit Income BDC 10Q 2022 Q1 Quarterly report

SCP Private Credit Income BDC 10-Q2022 Q1 Quarterly report

Content analysis

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarter Ended March 31, 2022

☐	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 814-01294

SCP Private Credit Income BDC LLC

(Exact name of registrant as specified in its charter)

Delaware

83-0634992

(State

of Incorporation)

(I.R.S. Employer

Identification No.)

500 Park Avenue

New York, N.Y.

10022

(Address of principal executive offices)

(Zip Code)

(212) 993-1670

(Registrant’s telephone number, including area code)

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

Title of Each Class

Trading

Symbol

Name of Each Exchange

on Which Registered

N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of March 31, 2022, there was no established public market for the registrant’s units. The issuer had 17,137,275 units outstanding as of April 29, 2022.

SCP PRIVATE CREDIT INCOME BDC LLC

FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2022

TABLE OF CONTENTS


	Index	Page No.
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Statements of Assets and Liabilities as of March 31, 2022 (unaudited) and December 31, 2021	3
	Consolidated Statements of Operations for the three months ended March 31, 2022 (unaudited) and the three months ended March 31, 2021 (unaudited)	4
	Consolidated Statements of Changes in Unitholders’ Capital for the three months ended March 31, 2022 (unaudited) and the three months ended March 31, 2021 (unaudited)	5
	Consolidated Statements of Cash Flows for the three months ended March 31, 2022 (unaudited) and the three months ended March 31, 2021 (unaudited)	6
	Consolidated Schedule of Investments as of March 31, 2022 (unaudited)	7
	Consolidated Schedule of Investments as of December 31, 2021	10
	Notes to Consolidated Financial Statements (unaudited)	13
	Report of Independent Registered Public Accounting Firm	29
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	40
Item 4.	Controls and Procedures	41
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	41
Item 1a.	Risk Factors	42
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3.	Defaults Upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	43
SIGNATURES		44

PART I. FINANCIAL INFORMATION

In this Quarterly Report, “Company”, “we”, “us”, and “our” refer to SCP Private Credit Income BDC LLC unless the context states otherwise.

Item 1.

Financial Statements

SCP Private Credit Income BDC LLC

Consolidated Statements of Assets and Liabilities

(in thousands, except unit amounts)


	March 31, 2022 (unaudited)		December 31, 2021
Assets
Investments at fair value:
Non-controlled/non-affiliated investments (cost: $455,911 and $436,217, respectively)	$	460,351	$	439,886
Cash		6,787		11,181
Interest receivable		2,755		2,253
Receivable for investments sold		134		32
Prepaid expenses		126		18

Total assets	$	470,153	$	453,370

Liabilities
Revolving credit facility due December 2023 (the “SPV Facility”) ($228,050 and $217,350 face amounts, respectively, reported net of unamortized debt issuance costs of $2,290 and $2,613, respectively. See note 5)	$	225,760	$	214,737
Revolving credit facility due December 2022 (the “Subscription Facility”) ($59,000 and $50,300 face amounts, respectively, reported net of unamortized debt issuance costs of $287 and $381, respectively. See note 5)		58,713		49,919
Distribution payable		—		7,277
Management fee payable (see note 3)		871		—
Incentive fee payable (see note 3)		1,274		2,749
Administration fee payable (see note 3)		88		79
Interest payable (see note 5)		1,700		1,601
Other liabilities and accrued expenses		819		895

Total liabilities	$	289,225	$	277,257

Commitments and contingencies (see note 6)

Unitholders’ Capital
Common Unitholders’ capital (17,137,275 and 17,137,275 units, respectively, issued and outstanding)		176,177		176,177
Accumulated distributable net earnings (loss)		4,751		(64	)

Total unitholders’ capital	$	180,928	$	176,113

Total liabilities and unitholders’ capital	$	470,153	$	453,370

Net asset value per unit	$	10.56	$	10.28

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Statement of Operations (unaudited)

(in thousands, except unit amounts)


	Three months ended March 31, 2022		Three months ended March 31, 2021
Investment Income:
Interest income from non-controlled/non-affiliated investments	$	8,522	$	3,317
Other income from non-controlled/non-affiliated investments		125		1

Total investment income		8,647		3,318

Expenses:
Management fees (see note 3)	$	871	$	479
Incentive fees (see note 3)		850		175
Administration fees (see note 3)		88		37
Interest and other credit facility expenses (see note 5)		2,589		999
Other general and administrative expenses		205		170

Total expenses		4,603		1,860

Net investment income	$	4,044	$	1,458

Realized and unrealized gain (loss) on investments and cash equivalents:
Net realized gain (loss) on non-controlled/non-affiliated investments and cash equivalents	$	—	$	(10	)
Net change in unrealized gain on non-controlled/non-affiliated investments and cash equivalents		771		456

Net realized and unrealized gain on non-controlled/non-affiliated investments and cash equivalents		771		446

Net Increase in Unitholders’ Capital Resulting From Operations	$	4,815	$	1,904

Net Income Per Unit	$	0.28	$	0.20

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Statement of Changes in Unitholders’ Capital (unaudited)

(in thousands, except unit amounts)


	Three months ended March 31, 2022		Three months ended March 31, 2021
Increase (decrease) in unitholders’ capital resulting from operations:
Net investment income	$	4,044	$	1,458
Net realized gain (loss)		—		(10	)
Net change in unrealized gain		771		456

Net increase in unitholders’ capital resulting from operations		4,815		1,904

Increase in unitholders’ capital resulting from capital activity
Contributions		—		—

Net increase (decrease) in unitholders’ capital resulting from capital activity		—		—

Total increase in unitholders’ capital		4,815		1,904
Unitholders’ capital, beginning of period		176,113		96,142

Unitholders’ capital, end of period	$	180,928	$	98,046

Capital unit activity (see note 7):
Units issued		—		—

Net increase from capital unit activity		—		—

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Statement of Cash Flows (unaudited)

(in thousands)


	Three months ended March 31, 2022			Three months ended March 31, 2021
Cash Flows from Operating Activities:
Net increase in unitholders’ capital resulting from operations	$	4,815		$	1,904
Adjustments to reconcile net increase in unitholders’ capital resulting from operations to net cash used in operating activities:
Net realized (gain) loss on investments and cash equivalents		—			10
Net change in unrealized gain on investments		(771	)		(456	)
(Increase) decrease in operating assets:
Purchase of investments		(40,490	)		(50,332	)
Net accretion of discount on investments		(541	)		(233	)
Proceeds from disposition of investments		21,394			3,749
Capitalization of payment-in-kind income		(57	)		—
Receivable for investments sold		(102	)		(539	)
Interest receivable		(502	)		(293	)
Prepaid expenses		(108	)		(85	)
Increase (decrease) in operating liabilities:
Payable for investments and cash equivalents purchased		—			28,316
Management fee payable		871			478
Incentive fee payable		(1,475	)		175
Administration fee payable		9			5
Interest payable		99			57
Other liabilities and accrued expenses		(76	)		33
Deferred financing costs		417			167

Net Cash Used in Operating Activities		(16,517	)		(17,044	)

Cash Flows from Financing Activities:
Cash distributions paid		(7,277	)		(3,378	)
Proceeds from borrowings		38,400			53,873
Repayments of borrowings		(19,000	)		(23,500	)

Net Cash Provided by Financing Activities		12,123			26,995

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(4,394	)		9,951
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		11,181			30,545

CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	6,787		$	40,496

Supplemental disclosure of cash flow information:
Cash paid for interest	$	2,490		$	942

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Schedule of Investments (unaudited)

March 31, 2022

(in thousands, except share/unit amounts)


Description	Industry	Spread above Index ⁽³⁾	Floor			Interest Rate ⁽¹⁾			Acquisition Date		Maturity Date		Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans — 254.3%
ACRES Commercial Mortgage, LLC⁽²⁾	Diversified Financial Services	L+705		1.00	%		8.05	%		12/24/2021		8/21/2028	$	12,660	$	12,414	$	12,407
Alimera Sciences, Inc.⁽²⁾	Pharmaceuticals	L+765		1.78	%		9.43	%		12/31/2019		7/1/2024		3,929		4,025		4,145
All State Ag Parts, LLC⁽²⁾	Trading Companies & Distributors	L+500		1.00	%		6.00	%		9/1/2021		9/1/2026		2,897		2,858		2,897
AmeriMark Intermediate Holdings, LLC⁽²⁾⁽⁵⁾	Internet & Catalog Retail	L+600		1.00	%		7.00	%		7/28/2021		10/15/2026		21,838		21,435		21,401
Apex Service Partners, LLC⁽²⁾	Diversified Consumer Services	L+525		1.00	%		6.25	%		11/5/2021		7/31/2025		18,426		18,126		18,333
Arcutis Biotherapeutics, Inc.⁽²⁾⁽⁴⁾	Pharmaceuticals	L+745		0.10	%		7.55	%		12/22/2021		1/1/2027		9,195		9,190		9,154
Ardelyx, Inc.⁽²⁾	Pharmaceuticals	L+795		0.10	%		8.18	%		2/23/2022		3/1/2027		3,319		3,300		3,296
Axcella Health, Inc.⁽²⁾	Pharmaceuticals	L+860		0.10	%		8.83	%		9/2/2021		9/1/2026		1,963		1,977		1,977
Basic Fun, Inc.⁽²⁾	Specialty Retail	L+550		1.00	%		6.50	%		10/30/2020		10/30/2023		960		952		960
BayMark Health Services, Inc.⁽²⁾	Health Care Providers & Services	L+500		1.00	%		6.00	%		6/29/2021		6/11/2027		15,902		15,754		15,902
BridgeBio Pharma, Inc.⁽²⁾⁽⁴⁾	Biotechnology	—		—			9.00	%		11/17/2021		11/17/2026		14,684		14,499		14,537
CC SAG Holdings Corp. (Spectrum Automotive) ⁽²⁾	Diversified Consumer Services	L+575		0.75	%		6.76	%		6/29/2021		6/29/2028		5,175		5,104		5,175
Centrexion Therapeutics, Inc.	Pharmaceuticals	L+725		2.45	%		9.70	%		6/28/2019		1/1/2024		3,204		3,272		3,276
Cerapedics, Inc.⁽²⁾	Health Care Equipment & Supplies	L+695		2.50	%		9.45	%		3/22/2019		3/1/2025		5,248		5,395		5,615
Enhanced Permanent Capital, LLC⁽²⁾⁽⁴⁾	Capital Markets	L+700		1.00	%		8.00	%		12/29/2020		12/29/2025		7,503		7,320		7,503
ENS Holdings III Corp. & ES Opco USA LLC (BlueFin)⁽²⁾	Trading Companies & Distributors	L+475		1.00	%		5.75	%		12/31/2019		12/31/2025		7,798		7,699		7,798
Enverus Holdings, Inc. (fka Drilling Info Holdings)⁽²⁾	IT Services	L+450		—			4.96	%		1/31/2020		7/30/2025		14,054		13,804		13,913
Erie Construction Mid-west, LLC⁽²⁾	Building Products	L+475		1.00	%		5.75	%		8/5/2021		7/30/2027		11,702		11,517		11,702
Foundation Consumer Brands, LLC⁽²⁾	Personal Products	L+550		1.00	%		6.50	%		2/12/2021		2/12/2027		14,223		13,922		14,223
Glooko, Inc.⁽²⁾	Health Care Technology	L+790		0.10	%		8.13	%		9/30/2021		10/1/2026		1,769		1,767		1,765
GSM Acquisition Corp.⁽²⁾	Leisure Equipment & Products	S+500		1.00	%		6.00	%		4/20/2021		11/16/2026		13,586		13,467		13,450
Higginbotham Insurance Agency, Inc.⁽²⁾	Insurance	L+550		0.75	%		6.25	%		11/25/2020		11/25/2026		8,191		8,089		8,191
High Street Buyer, Inc.⁽²⁾	Insurance	L+600		0.75	%		6.75	%		4/16/2021		4/16/2028		10,148		9,959		9,945
Inszone Mid, LLC⁽²⁾	Insurance	L+575		1.00	%		6.75	%		9/28/2021		6/30/2026		5,466		5,415		5,466
Ivy Fertility Services, LLC⁽²⁾	Health Care Providers & Services	L+625		1.00	%		7.25	%		12/22/2021		2/25/2026		9,170		9,019		9,010
Kid Distro Holdings, LLC (Distro Kid)⁽²⁾	Software	L+575		1.00	%		6.75	%		9/24/2021		10/1/2027		12,551		12,317		12,426
KORE Wireless Group, Inc.⁽²⁾⁽⁴⁾	Wireless Telecommunication Services	L+550		—			6.51	%		3/12/2019		12/21/2024		14,214		14,063		14,214
Maurices, Incorporated⁽²⁾	Specialty Retail	L+675		1.00	%		7.75	%		8/27/2021		6/1/2024		5,308		5,220		5,308
MMIT Holdings, LLC⁽²⁾	IT Services	L+625		1.00	%		7.25	%		9/21/2021		9/15/2027		12,972		12,777		12,972
MRI Software LLC⁽²⁾	Software	L+550		1.00	%		6.50	%		7/23/2019		2/10/2026		15,107		14,951		15,107
NAC Holding Corporation (Jaguar)⁽²⁾	Insurance	L+525		1.00	%		6.25	%		7/30/2021		9/28/2024		7,249		7,168		7,213
Neuronetics, Inc.⁽²⁾	Health Care Equipment & Supplies	L+765		1.66	%		9.31	%		3/2/2020		2/28/2025		3,056		3,116		3,117
Nexus Intermediate III, LLC (Vortex)⁽²⁾	Professional Services	L+550		0.75	%		6.25	%		12/13/2021		12/6/2027		5,992		5,891		5,887
Peter C. Foy & Associates Insurance Services, LLC⁽²⁾	Insurance	L+600		0.75	%		6.75	%		10/29/2021		11/1/2028		15,697		15,547		15,697
Pinnacle Treatment Centers, Inc.⁽²⁾	Health Care Providers & Services	L+575		1.00	%		6.75	%		1/22/2020		12/31/2022		4,684		4,671		4,684
Plastics Management, LLC⁽²⁾	Health Care Providers & Services	L+500		1.00	%		6.00	%		8/26/2021		8/18/2027		10,774		10,622		10,774
Revlon, Inc.⁽²⁾⁽⁴⁾	Personal Products	L+575		1.75	%		7.50	%		5/7/2021		5/7/2024		13,905		13,817		13,905
Rezolute, Inc.⁽²⁾	Biotechnology	L+875		0.12	%		8.98	%		4/14/2021		4/1/2026		1,206		1,207		1,206
RQM+ Corp.⁽²⁾	Life Sciences Tools & Services	L+575		1.00	%		6.75	%		8/20/2021		8/12/2026		6,964		6,902		6,964
RSC Acquisition, Inc.⁽²⁾	Insurance	L+550		0.75	%		6.25	%		10/5/2020		11/1/2026		5,110		4,976		5,110
Rubius Therapeutics, Inc.⁽²⁾⁽⁴⁾	Pharmaceuticals	L+550		2.10	%		7.60	%		3/12/2019		6/1/2026		7,872		8,049		8,049
RxSense Holdings LLC⁽²⁾	Diversified Consumer Services	L+500		1.00	%		6.00	%		3/17/2020		3/13/2026		14,750		14,566		14,750
scPharmaceuticals, Inc.⁽²⁾	Pharmaceuticals	L+795		2.23	%		10.18	%		9/17/2019		9/17/2023		686		701		700
SOC Telemed, Inc.⁽²⁾	Health Care Providers & Services	L+747		0.13	%		7.70	%		3/26/2021		4/1/2026		6,619		6,652		7,083
SunMed Group Holdings, LLC⁽²⁾	Health Care Equipment & Supplies	L+575		0.75	%		6.50	%		6/16/2021		6/16/2028		7,822		7,698		7,822

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Schedule of Investments (unaudited) (continued)

March 31, 2022

(in thousands)


Description	Industry	Spread above Index ⁽³⁾	Floor			Interest Rate ⁽¹⁾			Acquisition Date		Maturity Date		Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans (continued)
TAUC Management, LLC⁽²⁾	Health Care Providers & Services	L+525		1.00	%		6.25	%		2/12/2021		2/12/2027	$	9,280	$	9,160	$	9,187
Tilley Distribution, Inc.⁽²⁾	Trading Companies & Distributors	L+600		1.00	%		7.00	%		12/8/2021		12/31/2026		12,734		12,582		12,575
Transportation Insight, LLC⁽²⁾	Road & Rail	L+450		1.00	%		5.50	%		10/27/2021		12/18/2024		2,435		2,402		2,423
Ultimate Baked Goods Midco LLC (Rise Baking)⁽²⁾	Packaged Foods & Meats	L+625		1.00	%		7.25	%		8/12/2021		8/13/2027		8,273		8,084		8,066
Vapotherm, Inc.⁽⁴⁾	Health Care Equipment & Supplies	L+830		0.10	%		8.53	%		2/18/2022		2/1/2027		12,070		11,910		11,962
Vessco Midco Holdings, LLC⁽²⁾	Water Utilities	L+450		1.00	%		5.68	%		9/3/2021		11/2/2026		1,358		1,345		1,331
World Insurance Associates, LLC⁽²⁾	Insurance	L+575		1.00	%		6.75	%		10/12/2020		4/1/2026		19,538		19,113		19,538

Total Bank Debt/Senior Secured Loans															$	455,786	$	460,111


													Shares/ Units
Common Equity/Equity Interests/Warrants — 0.1%
Centrexion Therapeutics, Inc. Warrants†	Pharmaceuticals									6/28/2019				56,483		27		15
Senseonics Holdings, Inc. Common Stock†⁽⁴⁾	Health Care Equipment & Supplies									7/25/2019				79,501		23		157
Vapotherm, Inc.†⁽⁴⁾	Health Care Equipment & Supplies									2/18/2022				12,960		75		68

Total Common Equity/Equity Interests/Warrants															$	125	$	240

Total Investments⁽⁶⁾— 254.4%															$	455,911	$	460,351
Liabilities in Excess of Other Assets — (154.4%)																		(279,423	)

Net Assets — 100.0%																	$	180,928

(1)

Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate, the Secured Overnight Financing Rate (“SOFR”) or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of March 31, 2022.

(2)

Indicates an investment that is wholly or partially held by SCP Private Credit Income BDC LLC (the “Company”, “we”, “us” or “our”) through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC (the “SPV”). Such investments are pledged as collateral under the SPV Facility (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.

(3)	Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.

(4)

Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (“1940 Act”). If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of March 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 18.4% of the total assets of the Company.

(5)	AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.

(6)

Aggregate net unrealized depreciation for U.S. federal income tax purposes is $214; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $4,629 and $4,843, respectively, based on a tax cost of $460,565. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

†	Non-income producing security.

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Schedule of Investments (unaudited) (continued)

March 31, 2022

(in thousands)


Industry Classification	Percentage of Total Investments (at fair value) as of March 31, 2022
Insurance		15.5	%
Health Care Providers & Services		12.3	%
Diversified Consumer Services		8.3	%
Pharmaceuticals		6.7	%
Health Care Equipment & Supplies		6.2	%
Personal Products		6.1	%
Software		6.0	%
IT Services		5.8	%
Trading Companies & Distributors		5.1	%
Internet & Catalog Retail		4.6	%
Biotechnology		3.4	%
Wireless Telecommunication Services		3.1	%
Leisure Equipment & Products		2.9	%
Diversified Financial Services		2.7	%
Building Products		2.5	%
Packaged Foods & Meats		1.8	%
Capital Markets		1.6	%
Life Sciences Tools & Services		1.5	%
Specialty Retail		1.4	%
Professional Services		1.3	%
Road & Rail		0.5	%
Health Care Technology		0.4	%
Water Utilities		0.3	%

Total Investments		100.0	%

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Schedule of Investments

December 31, 2021

(in thousands, except share/unit amounts)


Description	Industry	Spread above Index ⁽³⁾	Libor Floor			Interest Rate ⁽¹⁾			Acquisition Date		Maturity Date		Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans —249.7%
ACRES Commercial Mortgage, LLC⁽²⁾	Diversified Financial Services	L+705		1.00	%		8.05	%		12/24/2021		8/21/2028	$	12,660	$	12,407	$	12,407
Alimera Sciences, Inc.⁽²⁾	Pharmaceuticals	L+765		1.78	%		9.43	%		12/31/2019		7/1/2024		3,929		4,014		4,007
All State Ag Parts, LLC⁽²⁾	Trading Companies & Distributors	L+500		1.00	%		6.00	%		9/1/2021		9/1/2026		2,748		2,709		2,748
AmeriMark Intermediate Holdings, LLC⁽⁵⁾	Internet & Catalog Retail	L+600		1.00	%		7.00	%		7/28/2021		10/15/2026		22,191		21,763		21,747
Apex Service Partners, LLC⁽²⁾	Diversified Consumer Services	L+525		1.00	%		6.25	%		11/5/2021		7/31/2025		14,931		14,676		14,670
Arcutis Biotherapeutics, Inc.⁽²⁾⁽⁴⁾	Pharmaceuticals	L+745		0.10	%		7.55	%		12/22/2021		1/1/2027		9,195		9,157		9,154
Axcella Health, Inc.⁽²⁾	Pharmaceuticals	L+860		0.10	%		8.70	%		9/2/2021		9/1/2026		1,963		1,971		1,968
Basic Fun, Inc.⁽²⁾	Specialty Retail	L+550		1.00	%		6.50	%		10/30/2020		10/30/2023		1,297		1,283		1,297
BayMark Health Services, Inc.⁽²⁾	Health Care Providers & Services	L+500		1.00	%		6.00	%		6/29/2021		6/11/2027		15,639		15,489		15,639
BridgeBio Pharma, Inc.⁽²⁾⁽⁴⁾	Biotechnology	—		—			9.00	%		11/17/2021		11/17/2026		14,627		14,419		14,407
CC SAG Holdings Corp. (Spectrum Automotive) ⁽²⁾	Diversified Consumer Services	L+575		0.75	%		6.50	%		6/29/2021		6/29/2028		5,148		5,075		5,148
Centrexion Therapeutics, Inc	Pharmaceuticals	L+725		2.45	%		9.70	%		6/28/2019		1/1/2024		3,204		3,261		3,268
Cerapedics, Inc.⁽²⁾	Health Care Equipment & Supplies	L+695		2.50	%		9.45	%		3/22/2019		3/1/2025		5,248		5,376		5,366
Community Brands ParentCo, LLC (f/k/a Ministry Brands)⁽²⁾	Software	L+400		1.00	%		5.00	%		6/11/2021		12/2/2022		17,770		17,590		17,770
Drilling Info Holdings, Inc.⁽²⁾	IT Services	L+450		—			4.60	%		1/31/2020		7/30/2025		14,090		13,822		14,090
Enhanced Permanent Capital, LLC⁽²⁾⁽⁴⁾	Capital Markets	L+700		1.00	%		8.00	%		12/29/2020		12/29/2025		5,554		5,417		5,554
ENS Holdings III Corp. & ES Opco USA LLC (BlueFin)⁽²⁾	Trading Companies & Distributors	L+475		1.00	%		5.75	%		12/31/2019		12/31/2025		7,527		7,422		7,527
Erie Construction Mid-west, LLC⁽²⁾	Building Products	L+475		1.00	%		5.75	%		8/5/2021		7/30/2027		11,732		11,538		11,732
Foundation Consumer Brands, LLC⁽²⁾	Personal Products	L+638		1.00	%		7.38	%		2/12/2021		2/12/2027		14,223		13,910		14,223
Glooko, Inc.⁽²⁾	Health Care Technology	L+790		0.10	%		8.00	%		9/30/2021		10/1/2026		1,769		1,764		1,760
GSM Acquisition Corp.⁽²⁾	Leisure Equipment & Products	L+500		1.00	%		6.00	%		4/20/2021		11/16/2026		14,170		14,039		14,170
Higginbotham Insurance Agency, Inc.⁽²⁾	Insurance	L+550		0.75	%		6.25	%		11/25/2020		11/25/2026		8,212		8,105		8,212
High Street Buyer, Inc.⁽²⁾	Insurance	L+600		0.75	%		6.75	%		4/16/2021		4/16/2028		9,241		9,064		9,241
Inszone Mid, LLC⁽²⁾	Insurance	L+575		1.00	%		6.75	%		9/28/2021		6/30/2026		4,713		4,668		4,690
Ivy Fertility Services, LLC⁽²⁾	Health Care Providers & Services	L+625		1.00	%		7.25	%		12/22/2021		2/25/2026		9,170		9,011		9,010
Kid Distro Holdings, LLC (Distro Kid)⁽²⁾	Software	L+600		1.00	%		7.00	%		9/24/2021		10/1/2027		12,583		12,340		12,331
KORE Wireless Group, Inc.⁽²⁾⁽⁴⁾	Wireless Telecommunication Services	L+550		—			5.72	%		3/12/2019		12/21/2024		14,251		14,087		14,251
Maurices, Incorporated⁽²⁾	Specialty Retail	L+675		1.00	%		7.75	%		8/27/2021		6/1/2024		4,518		4,437		4,518
MMIT Holdings, LLC⁽²⁾	IT Services	L+625		1.00	%		7.25	%		9/21/2021		9/15/2027		13,126		12,921		13,126
MRI Software LLC⁽²⁾	Software	L+550		1.00	%		6.50	%		7/23/2019		2/10/2026		13,872		13,719		13,872
NAC Holding Corporation (Jaguar)⁽²⁾	Insurance	L+525		1.00	%		6.25	%		7/30/2021		9/28/2024		6,737		6,655		6,703
Neuronetics, Inc.⁽²⁾	Health Care Equipment & Supplies	L+765		1.66	%		9.31	%		3/2/2020		2/28/2025		3,056		3,107		3,108
Nexus Intermediate III, LLC (Vortex)⁽²⁾	Professional Services	L+550		0.75	%		6.25	%		12/13/2021		12/6/2027		5,992		5,888		5,887
Peter C. Foy & Associates Insurance Services, LLC⁽²⁾	Insurance	L+600		0.75	%		6.75	%		10/29/2021		11/1/2028		14,668		14,524		14,521
Pinnacle Treatment Centers, Inc.⁽²⁾	Health Care Providers & Services	L+575		1.00	%		6.75	%		1/22/2020		12/31/2022		4,696		4,678		4,696
Plastics Management, LLC⁽²⁾	Health Care Providers & Services	L+500		1.00	%		6.00	%		8/26/2021		8/18/2027		7,278		7,174		7,205
Revlon, Inc.⁽²⁾⁽⁴⁾	Personal Products	L+575		1.75	%		7.50	%		5/7/2021		5/7/2024		13,905		13,807		13,905
Rezolute, Inc.⁽²⁾	Biotechnology	L+875		0.12	%		8.87	%		4/14/2021		4/1/2026		1,206		1,204		1,203
RQM+ Corp.⁽²⁾	Life Sciences Tools & Services	L+575		1.00	%		6.75	%		8/20/2021		8/12/2026		6,982		6,916		6,964
RSC Acquisition, Inc.⁽²⁾	Insurance	L+550		0.75	%		6.25	%		10/5/2020		11/1/2026		5,123		4,982		5,123
Rubius Therapeutics, Inc.⁽²⁾⁽⁴⁾	Pharmaceuticals	L+550		2.10	%		7.60	%		3/12/2019		6/1/2026		7,872		8,028		8,029
RxSense Holdings LLC⁽²⁾	Diversified Consumer Services	L+500		1.00	%		6.00	%		3/17/2020		3/13/2026		10,543		10,391		10,543
scPharmaceuticals, Inc.⁽²⁾	Pharmaceuticals	L+795		2.23	%		10.18	%		9/17/2019		9/17/2023		801		814		813
SOC Telemed, Inc.⁽²⁾	Health Care Providers & Services	L+747		0.13	%		7.60	%		3/26/2021		4/1/2026		6,619		6,634		6,635

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Schedule of Investments (continued)

December 31, 2021

(in thousands)


Description	Industry	Spread above Index ⁽³⁾	Libor Floor			Interest Rate ⁽¹⁾			Acquisition Date		Maturity Date		Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans (continued)
SunMed Group Holdings, LLC⁽²⁾	Health Care Equipment & Supplies	L+575		0.75	%		6.50	%		6/16/2021		6/16/2028	$	7,842	$	7,713	$	7,763
TAUC Management, LLC⁽²⁾	Health Care Providers & Services	L+525		1.00	%		6.25	%		2/12/2021		2/12/2027		7,907		7,803		7,827
Tilley Chemical Buyer, Inc.⁽²⁾	Trading Companies & Distributors	L+600		1.00	%		7.00	%		12/8/2021		12/31/2026		9,798		9,677		9,676
Transportation Insight, LLC⁽²⁾	Road & Rail	L+450		1.00	%		5.50	%		10/27/2021		12/18/2024		2,300		2,266		2,265
Ultimate Baked Goods Midco LLC (Rise Baking)⁽²⁾	Packaged Foods & Meats	L+625		1.00	%		7.25	%		8/12/2021		8/13/2027		8,199		8,004		7,994
Vessco Midco Holdings, LLC⁽²⁾	Water Utilities	L+450		1.00	%		5.50	%		9/3/2021		11/2/2026		1,324		1,311		1,311
World Insurance Associates, LLC⁽²⁾	Insurance	L+575		1.00	%		6.75	%		10/12/2020		4/1/2026		19,587		19,137		19,587

Total Bank Debt/Senior Secured Loans															$	436,167	$	439,661

Common Equity/Equity Interests/Warrants — 0.1%														Shares/ Units
Centrexion Therapeutics, Inc. Warrants†	Pharmaceuticals									6/28/2019				56,483		27		13
Senseonics Holdings, Inc. Common Stock†⁽⁴⁾	Health Care Equipment & Supplies									7/25/2019				79,501		23		212

Total Common Equity/Equity Interests/Warrants															$	50	$	225

Total Investments⁽⁶⁾— 249.8%															$	436,217	$	439,886
Liabilities in Excess of Other Assets — (149.8%)																		(263,773	)

Net Assets — 100.0%																	$	176,113

(1)

Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2021.

(2)

Indicates an investment that is wholly or partially held by SCP Private Credit Income BDC LLC (the “Company”, “we”, “us” or “our”) through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC (the “SPV”). Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.

(3)	Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor.

(4)

Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (“1940 Act”). If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 14.5% of the total assets of the Company.

(5)	AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.

(6)

Aggregate net unrealized depreciation for U.S. federal income tax purposes is $984; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $3,772 and $4,756, respectively, based on a tax cost of $440,870. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

†	Non-income producing security.

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Consolidated Schedule of Investments (continued)

December 31, 2021

(in thousands)


Industry Classification	Percentage of Total Investments (at fair value) as of December 31, 2021
Insurance		15.5	%
Health Care Providers & Services		11.6	%
Software		10.0	%
Diversified Consumer Services		6.9	%
Personal Products		6.4	%
Pharmaceuticals		6.2	%
IT Services		6.2	%
Internet & Catalog Retail		5.0	%
Trading Companies & Distributors		4.5	%
Health Care Equipment & Supplies		3.7	%
Biotechnology		3.6	%
Wireless Telecommunication Services		3.2	%
Leisure Equipment & Products		3.2	%
Diversified Financial Services		2.8	%
Building Products		2.7	%
Packaged Foods & Meats		1.8	%
Life Sciences Tools & Services		1.6	%
Professional Services		1.3	%
Specialty Retail		1.3	%
Capital Markets		1.3	%
Road & Rail		0.5	%
Health Care Technology		0.4	%
Water Utilities		0.3	%

Total Investments		100.0	%

See notes to consolidated financial statements.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited)

March 31, 2022

(in thousands, except unit amounts)

Note 1. Organization

SCP Private Credit Income BDC LLC (the “Company”, “we”, “us” or “our”) is a Delaware limited liability company formed on May 18, 2018. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (“the 1940 Act”). Furthermore, as the Company is an investment company, it applies the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company was formed primarily to provide investors with attractive long-term returns through investments made pursuant to the investment strategy of the Company described below (the Company’s investments in portfolio companies are referred to herein as “Portfolio Investments”).

On October 5, 2018 (the “Initial Closing Date”), the Company closed on $326,000 in capital commitments. On March 12, 2019, the sale and issuance of 2,800,000 units, at an aggregate purchase price of $28,000 ($10.00 per unit) occurred and the Company commenced material operations. As of March 31, 2022, $176,500 of capital commitments were drawn and $149,500 were unfunded.

The Company has implemented a corporate lending strategy focused on sourcing, underwriting and managing a diverse portfolio of private senior secured loans primarily to upper middle market companies (generally, loan sizes of $100,000 to $300,000 to companies with earnings before interest, tax, depreciation and amortization (“EBITDA”) between approximately $25,000 and $100,000) across the United States. In addition to senior secured loans to upper middle market companies, the Company intends to invest a portion of its assets in non-traditional asset-based loans and first lien loans to rapidly growing healthcare companies. The Company also expects that some of its investments will contain delayed-draw term loan type features and/or other types of unfunded commitments.

The offering period of the Company ended on April 5, 2019 (the “Offering Period”). The investment period of the Company ends on December 31, 2022. The term of the Company will be six years from the end of the Offering Period unless the Company is liquidated earlier as set forth in the Limited Liability Company Agreement of the Company (as amended, restated or otherwise modified from time to time, the “LLC Agreement”), but may be extended by the board of directors for up to two consecutive one year periods upon approval of the Company’s independent directors and the approval of unitholders of the Company (“Unitholders”), which approval will be obtained through a non-1940 Act vote as described in the LLC Agreement. The Company may be dissolved and its affairs wound up prior to the end of the term under the circumstances set forth in the LLC Agreement. The fiscal year end of the Company is December 31.

Note 2. Summary of Significant Accounting Policies

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to current period presentation.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2022.

In the opinion of management, all adjustments which are of a normal recurring nature considered necessary for the fair presentation of financial statements, have been included.

The significant accounting policies consistently followed by the Company are:

(a)

Investment transactions are accounted for on the trade date;

(b)

In accordance with GAAP and the 1940 Act, the Company’s assets will generally be valued as follows:

(i)

securities or other instruments (other than as referred to in clauses (ii) and (iii) below) for which market quotes are readily available will be valued based on quotes obtained from a quotation reporting system, market makers or pricing services (when deemed to represent fair value under U.S. GAAP);

(ii)

exchange-traded options, futures and options on futures will be valued at the settlement price determined by the exchange or through the use of a model such as Black-Scholes;

(iii)

short-term investments with maturities of sixty (60) days or less generally will be valued at amortized cost; and

(iv)

securities, loans or other instruments for which market quotes are not readily available will be valued as described below:

the quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of SLR Capital Partners, LLC (the “Adviser”) responsible for the portfolio investment;

preliminary valuation conclusions are then documented and discussed with senior management of the Adviser;

the audit committee of the Board of Directors ( the “Board”) reviews the preliminary valuations of the Adviser and third party valuation specialist, if any, and responds to the valuation recommendations to reflect any comments; and

the Board discusses valuations and determines the fair value of each investment in the Company’s portfolio in good faith based on the input of the Adviser, the audit committee, and third party valuation specialist, if any, that may from time to time be engaged.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

The valuation principles set forth above may be modified from time to time without notice to Unitholders, in whole or in part, as determined by the Board in its sole discretion.

When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material.

Investments are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the three months ended March 31, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.

ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.

Level 3: Unobservable inputs for the asset or liability.

In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.

(c)

Gains or losses on investments are calculated by using the specific identification method.

(d)

The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

(e)

The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.

(f)

Book and tax basis differences relating to Unitholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.

(g)

Distributions to Unitholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.

(h)

In accordance with Regulation S-X and ASC Topic 810—Consolidation, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.

(i)

The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against the U.S. dollar on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.

(j)

In accordance with ASC 835-30, the Company reports origination and other expenses related to certain debt issuances, if any, as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.

(k)

The Company records expenses related to applicable equity offering costs as a charge to capital upon the sale of units, in accordance with ASC 946-20-25.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

(l)

Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.

(m)

The Company records expenses directly related to its organization as incurred.

(n)

The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.

Recent Accounting Pronouncements

In March 2020, the FASB issued Accounting Standards Update No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is evaluating the potential impact that the adoption of this guidance will have on the Company’s financial statements.

Note 3. Agreements and Related Party Transactions

The Company has entered into an investment management agreement with the Adviser (the “Investment Management Agreement”) pursuant to which it will pay management fees, administrative coordinator fees and incentive fees to the Adviser. The Company will pay the Adviser a fee for investment advisory and management services consisting of two components: a base management fee and an incentive fee. The Company will also pay the Adviser (in its capacity as Administrative Coordinator, defined herein) an administration fee for administrative and coordination services. The cost of the base management fee, the incentive fee, and the administration fee will be borne by the Unitholders.

Management Fees and Administration Fees

The Company will pay the Adviser a management fee (the “Management Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (each such date, the “Management Fee Calculation Date”), in an amount equal to 1.5% per annum of Invested Capital (defined as, as of any date, the sum of (i) capital contributions to the Company plus (ii) the total amount of credit drawn on subscription credit facilities), and payable quarterly in arrears after such Management Fee Calculation Date.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Pursuant to the Investment Management Agreement, the Adviser has also been appointed to provide administrative and coordination services to the Company (in such capacity, the “Administrative Coordinator”). The Company will pay the Administrative Coordinator, a fee (the “Administration Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (the “Administration Fee Calculation Date”), in an amount equal to 0.08% per annum of the average Cost Basis (defined as the aggregate accreted and amortized cost of all portfolio investments, including any amounts reinvested in investments and the cost of investments acquired using leverage), as measured on the last day of the preceding quarter and the last day of the current quarter for the period ended and payable quarterly in arrears after such Administration Fee Calculation Date. The Administrative Coordinator will be responsible for all expenses of its own staff responsible for (i) certain on-going, routine, non-investment-related administrative services for the Company, (ii) the coordination of various third party services needed or required by the Company and (iii) certain Unitholder servicing functions.

Each of the Management Fee and the Administration Fee will be appropriately adjusted for any stub period. Such fees will be paid out of net current income and/or disposition proceeds or, to the extent such amounts are not available, from unfunded capital commitments that will be drawn down, or borrowings of the Company. In the event that the Adviser arranges for the Company to pay any portion of a placement fee to a placement agent, the amount of management fees otherwise payable shall be reduced by an amount equal to 100% of such payment to the placement agent.

Incentive Fee

The Company will make distributions out of two categories: Current Proceeds and Disposition Proceeds (collectively referred to as “Investment Proceeds”). “Disposition Proceeds” means all amounts received by the Company upon the disposition of an investment, including full or partial repayments or amortization of principal (but excluding Current Proceeds). “Current Proceeds” means all proceeds from investments, including interest income, fee income, warrant gains, prepayment fees and exit fees, other than Disposition Proceeds. The Adviser will apportion each Unitholder’s pro rata share of Investment Proceeds between Disposition Proceeds and Current Proceeds. Amounts of Investment Proceeds apportioned to Unitholders will be divided between and distributed to Unitholders, on the one hand, and the Adviser, on the other hand, in the following amounts and order of priority:

(i) First, Return of Capital Contributions: 100% of amounts constituting Disposition Proceeds to Unitholders until each Unitholder has received cumulative distributions of Disposition Proceeds pursuant to this clause (i) equal to each Unitholder’s total capital contributions to the Company (including amounts contributed to pay Management Fees, Administration Fees, Organizational Expenses and other Company expenses). Amounts constituting Current Proceeds proceed to clause (ii) and are not returned under this clause (i);

(ii) Second, Unitholder Preferred Return: 100% of all remaining Investment Proceeds to Unitholders until they have each received distributions, without duplication, pursuant to this clause (ii) and clause (iv) below equal to a 6% per annum return, compounded annually, on Unitholders’ unreturned capital contributions to the Company (including amounts contributed to pay Management Fees, Administration Fees, Organizational Expenses and other Company expenses);

(iii) Third, Adviser Catch Up: 80% of all remaining Investment Proceeds to the Adviser, as a “catch up” distribution with respect to its incentive fee, until the Adviser has received distributions of Investment Proceeds with respect to Unitholders pursuant to this clause (iii) equal to 15% of the total amounts distributed to Unitholders and the Adviser with respect to Unitholders pursuant to clause (ii) above and this clause (iii); and

(iv) Fourth, 85%/15% units: 85% to Unitholders and 15% to the Adviser as an incentive fee.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

In no event will the Adviser receive amounts attributable to Disposition Proceeds that, as of any distribution or payment date, exceeds 20% of cumulative realized capital gains net of all cumulative realized capital losses and unrealized capital depreciation.

The Adviser may also elect not to receive all or any portion of the incentive fee that would otherwise be distributed to it, and may cause any or all amounts subsequently available for distribution to the Unitholders to be distributed to the Adviser until it has received the same aggregate amount of incentive fees had it not previously waived receipt of incentive fees.

The Adviser will be entitled to withhold from any distributions, in its discretion, any required tax withholdings. Amounts of taxes paid or withheld from amounts otherwise distributable to a Unitholder will be deemed distributed for purposes of the calculations above.

Upon liquidation of the Company, the Adviser will be required to restore funds to the Company for distribution to the Unitholders if and to the extent that the Adviser has received cumulative incentive fees in excess of the incentive fees that would have been payable to the Adviser on an aggregate basis covering all transactions of the Company; provided, however, that in no event will the Adviser be required to contribute an aggregate amount in excess of 100% of the net amount distributed to the Adviser (net of taxes) on account of its incentive fees. In addition, the Adviser will apply an interim incentive fee adjustment at the end of each fiscal year so that, in the event of any over-distribution of incentive fee to the Adviser (measured with respect to each Unitholder using the fair value of the Company’s portfolio at the end of the applicable fiscal year as if the Company were to liquidate on such date), future distributions that would, absent such interim incentive fee adjustment, otherwise be distributed to the Adviser as an incentive fee, shall be distributed to such Unitholder until such over-distribution (net of taxes payable by the Adviser with respect to such incentive fee) has been eliminated.

For the three months ended March 31, 2022 and March 31, 2021, the Company incurred $871 and $479, respectively, in Management Fees, $88 and $37, respectively, in Administration Fees and $850 and $175, respectively, in Incentive Fees.

The aggregate amount of certain operating expenses relating to Unitholders investing directly in the Company will not exceed the Operating Expense Cap, calculated as follows: (A) if the Company has less than or equal to $400,000 in capital commitments, an amount equal to the sum of (x) the product of the capital commitments and 0.0025 and (y) $1,250, or (B) if the Company has greater than $400,000 in capital commitments, $2,250. Any amount in excess of the Operating Expense Cap for any fiscal year will be paid by the Adviser. For the avoidance of doubt, the Operating Expense Cap will not apply to any fees, costs, expenses and liabilities allocable to persons investing indirectly in the Company through any Unitholder.

The Adviser or Administrative Coordinator and/or their affiliates has advanced organizational and offering expenses to the Company, which include organizational fees, costs, expenses and liabilities of the Company, including legal expenses, incurred in connection with the initial offering of Units and the formation and establishment of the Company. The Adviser or Administrative Coordinator (or such affiliate) has been reimbursed by the Company for such advanced costs and expenses in an amount not to exceed $500. $308 of offering expenses were charged to capital and $84 of organizational costs were expensed in 2019.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Note 4. Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:

Level 1. Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.

Level 2. Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

Quoted prices for similar assets or liabilities in active markets;

Quoted prices for identical or similar assets or liabilities in non-active markets;

Pricing models whose inputs are observable for substantially the full term of the asset or liability; and

Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.

Level 3. Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).

Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

The following tables present the balances of assets measured at fair value on a recurring basis, as of March 31, 2022 and December 31, 2021:

Fair Value Measurements

As of March 31, 2022


	Level 1		Level 2		Level 3		Total
Assets:
Bank Debt/Senior Secured Loans	$	—	$	—	$	460,111	$	460,111
Common Equity/Equity Interests/Warrants		157		—		83		240

Total Investments	$	157	$	—	$	460,194	$	460,351

Fair Value Measurements

As of December 31, 2021


	Level 1		Level 2		Level 3		Total
Assets:
Bank Debt/Senior Secured Loans	$	—	$	—	$	439,661	$	439,661
Common Equity/Equity Interests/Warrants		212		—		13		225

Total Investments	$	212	$	—	$	439,674	$	439,886

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

The following table provides a summary of the changes in fair value of Level 3 assets for the three months ended March 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at March 31, 2022:


	Bank Debt/Senior Secured Loans			Common Equity/Equity Interests/Warrants			Total
Fair value, December 31, 2021	$	439,661		$	13		$	439,674
Total gains or losses included in earnings:
Net realized gain (loss)		—			—			—
Net change in unrealized gain (loss)		831			(5	)		826
Purchase of investment securities		41,014			75			41,089
Proceeds from dispositions of investment securities		(21,395	)		—			(21,395	)
Transfers into Level 3		—			—			—
Transfers out of Level 3		—			—			—

Fair value, March 31, 2022	$	460,111		$	83		$	460,194

Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
Net change in unrealized gain (loss)	$	1,011		$	(5	)	$	1,006

The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021:


	Bank Debt/Senior Secured Loans			Common Equity/Equity Interests/Warrants			Total
Fair value, December 31, 2020	$	165,334		$	30		$	165,364
Total gains or losses included in earnings:
Net realized gain		16			—			16
Net change in unrealized gain		2,437			6			2,443
Purchase of investment securities		378,842			—			378,842
Proceeds from dispositions of investment securities		(106,968	)		—			(106,968	)
Transfers into Level 3		—			—			—
Transfers out of Level 3⁽¹⁾		—			(23	)		(23	)

Fair value, December 31, 2021	$	439,661		$	13		$	439,674

Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
Net change in unrealized gain (loss)	$	2,860		$	(1	)		2,859

(1)	On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Quantitative Information about Level 3 Fair Value Measurements

The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.

Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.

Quantitative information about the Company’s Level 3 asset fair value measurements as of March 31, 2022 is summarized in the table below:

Asset or
Liability

Fair Value at
March 31, 2022

Principal Valuation
Technique/Methodology

Unobservable Input

Range (Weighted
Average)

Bank Debt / Senior Secured Loans

Asset

460,111

Income Approach

Market Yield

5.5% – 11.6% (7.6%)

Common Equity/Equity Interests/Warrants

Asset

Market Approach

Volatility

24.2% – 24.2% (24.2%)

Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, would result in a significantly lower or higher fair value measurement for such assets. Generally, an increase in market yields may result in a decrease in the fair value of certain of the Company’s investments.

Quantitative information about the Company’s Level 3 asset fair value measurements as of December 31, 2021 is summarized in the table below:

Asset or
Liability

Fair Value at
December 31,
2021

Principal Valuation
Technique/Methodology

Unobservable Input

Range (Weighted
Average)

Bank Debt / Senior Secured Loans

Asset

439,661

Income Approach

Market Yield

4.7% – 14.0% (7.2%)

Common Equity/Equity Interests/Warrants

Asset

Market Approach

Volatility

22.0% – 22.0% (22.0%)

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Note 5. Debt

SPV Facility—During the first quarter of 2019, the Company, through its wholly-owned subsidiary, SCP Private Credit Income BDC SPV LLC (the “SPV”), entered into the $100,000 SPV Facility with JPMorgan Chase Bank, N.A. acting as administrative agent. The commitment can also be expanded up to $400,000. The stated interest rate on the SPV Facility is LIBOR plus 2.75% with no LIBOR floor requirement and the current final maturity date is December 31, 2023. The fee on undrawn commitments is generally 0.875%. The SPV Facility is secured by all of the assets held by the SPV. Under the terms of the SPV Facility, the Company and SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV also includes usual and customary events of default for credit facilities of this nature. On November 18, 2019, the Company amended the SPV Facility, reducing commitments to $75,000. On February 27, 2021, the Company again amended the SPV Facility, increasing commitments to $100,000. On July 16, 2021, the Company entered into an amended SPV Facility, which increased commitments to $125,000, and on August 18, 2021 entered into a second amended SPV Facility which increased commitments to $200,000 and extended the final maturity date to December 31, 2023. On November 2, 2021, the Company entered into Amendment No. 1 to the second amended SPV Facility, which increased commitments to $275,000. There were $228,050 of borrowings outstanding as of March 31, 2022 under the SPV Facility.

Subscription Facility—During the first quarter of 2019, the Company established the $35,000 Subscription Facility with East West Bank, and subsequently entered into an amendment on June 24, 2019, which increased commitments from $35,000 to $50,000. On March 5, 2021, the Company entered into a second amendment. Under the second amendment, commitments were increased from $50,000 to $75,000, the stated interest rate on the Subscription Facility is LIBOR plus 2.70% and the maturity date was extended. On October 4, 2021, the Company entered into an amended and restated loan and security agreement, which increased commitments to $100,000 and extended the maturity date to December 31, 2022. Under the terms of the Subscription Facility, the Company has made certain customary representations and warranties, and is required to comply with various covenants, including reporting requirements and other customary requirements for similar credit facilities. The Subscription Facility also includes usual and customary events of default for credit facilities of this nature. There were $59,000 of borrowings outstanding as of March 31, 2022 under the Subscription Facility.

The average annualized interest cost for borrowings for the three months ended March 31, 2022 and March 31, 2021 was 2.93% and 3.35%, respectively. These costs are exclusive of other credit facility expenses such as unused fees and fees paid to the back-up servicer, if any. The maximum amount borrowed on the credit facilities during the three months ended March 31, 2022 and March 31, 2021 was $296,550 and $107,450, respectively.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Note 6. Commitments and Contingencies

The Company had unfunded debt commitments to various revolving and delayed-draw term loans. The total amount of these unfunded commitments as of March 31, 2022 and December 31, 2021 is $98,265 and $106,337, respectively, comprised of the following:


	March 31, 2022		December 31, 2021
Arcutis Biotherapeutics, Inc.	$	18,390	$	18,390
BridgeBio Pharma, Inc.		9,751		9,751
CC SAG Holdings Corp. (Spectrum Automotive)		7,925		7,965
Vessco Midco Holdings, LLC		5,825		5,862
NAC Holdings Corporation		5,770		6,535
Glooko, Inc.		5,308		5,308
Inszone Mid, LLC		4,503		5,273
High Street Buyer, Inc.		4,334		1,080
Maurices, Incorporated		3,727		4,969
Transportation Insight, LLC		3,678		3,819
Vapotherm, Inc.		3,018		—
Ardelyx, Inc.		2,716		—
Ivy Fertility Services, LLC		1,917		1,917
Enverus Holdings, Inc.		1,758		1,758
GSM Acquisition Corp.		1,689		1,138
RQM+ Corp.		1,615		1,615
Erie Construction Mid-west, LLC		1,593		1,593
RxSense Holdings, LLC		1,558		1,558
Nexus Intermediate III, LLC (Vortex)		1,264		1,264
Basic Fun, Inc.		1,201		864
Kid Distro Holdings, LLC		1,121		1,121
Plastics Management, LLC		1,006		4,529
MMIT Holdings, LLC		971		850
Foundation Consumer Brands, LLC		967		967
SOC Telemed, Inc.		946		946
MRI Software LLC		897		2,170
Tilley Chemical Buyer, Inc.		746		2,918
Apex Service Partners, LLC		681		4,221
Rezolute, Inc.		603		1,206
BayMark Health Services, Inc.		579		880
Peter C. Foy & Associates Insurance Services, LLC		570		1,639
SunMed Group Holdings, LLC		433		433
World Insurance Associates, LLC		356		356
Pinnacle Treatment Centers, Inc.		307		553
Ultimate Baked Goods Midco LLC		245		339
All States Ag Parts, LLC		172		328
TAUC Management, LLC		125		1,498
Neuronetics, Inc.		—		437
ENS Holdings III Corp. & ES Opco USA LLC		—		287

Total Commitments	$	98,265	$	106,337

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of March 31, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.

In the normal course of its business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.

Note 7. Unitholders’ Capital

Transactions in Unitholders’ capital were as follows:


	Three months ended March 31, 2022		Three months ended March 31, 2021
Units at beginning of period		17,137,275		9,586,174
Units issued		—		—

Units issued and outstanding at end of period		17,137,275		9,586,174

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Note 8. Financial Highlights

The following is a schedule of financial highlights for the three months ended March 31, 2022 and March 31, 2021:


	Three months ended March 31, 2022			Three months ended March 31, 2021
Per Share Data: (a)
Net asset value per unit, beginning of period	$	10.28		$	10.03

Net investment income		0.24			0.15
Net realized and unrealized gain		0.04			0.05

Net increase in Unitholders’ capital resulting from operations		0.28			0.20
Distributions to Unitholders:
From net investment income		—			—

Net asset value per unit, end of period	$	10.56		$	10.23

Total Return (b)(c)		2.72	%		1.99	%
Unitholders’ capital, end of period	$	180,928		$	98,046
Units outstanding, end of period		17,137,275			9,586,174

Ratios to average net assets of Unitholders’ Capital (c):
Net investment income		2.30	%		1.52	%

Operating expenses		1.14	%		0.89	%
Interest and other credit facility expenses		1.47	%		1.04	%

Total expenses		2.61	%		1.93	%

Average debt outstanding	$	281,110		$	89,110
Portfolio turnover ratio		4.8	%		2.0	%

(a)	Calculated using the average units outstanding method. Weighted average units outstanding for the three months ended March 31, 2022 and March 31, 2021 were 17,137,275 and 9,586,174, respectively.

(b)	Calculated as the change in NAV per unit during the period plus distributions declared per unit, divided by the beginning NAV per unit. Total return does not include a sales load.

(c)	Not annualized for periods less than one year.

SCP Private Credit Income BDC LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

March 31, 2022

(in thousands, except unit amounts)

Note 9. Subsequent Events

The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. There have been no subsequent events that require recognition or disclosure in these consolidated financial statements.

Report of Independent Registered Public Accounting Firm

To the Unitholders’ and Board of Directors

SCP Private Credit Income BDC LLC:

Results of Review of Interim Financial Information

We have reviewed the consolidated statement of assets and liabilities of SCP Private Credit Income BDC LLC (and subsidiaries) (the Company), including the consolidated schedule of investments, as of March 31, 2022, the related consolidated statements of operations, changes in unitholders’ capital, and cash flows for the three-month periods ended March 31, 2022 and 2021, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statement of assets and liabilities, including the consolidated schedule of investments, of the Company as of December 31, 2021, and the related consolidated statements of operations, changes in unitholders’ capital, and cash flows for the year then ended (not presented herein); and in our report dated March 1, 2022, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated statement of assets and liabilities, including the consolidated schedule of investments, as of December 31, 2021, is fairly stated, in all material respects, in relation to the consolidated statement of assets and liabilities, including the consolidated schedule of investments, from which it has been derived.

Basis for Review Results

This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ KPMG LLP

New York, New York

May 3, 2022

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about SCP Private Credit Income BDC LLC, our current and prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

•

our future operating results, including our ability to achieve objectives as a result of the current COVID-19 pandemic;

•

our business prospects and the prospects of our portfolio companies;

•

the impact of investments that we expect to make;

•

our contractual arrangements and relationships with third parties;

•

the dependence of our future success on the general economy and its impact on the industries in which we invest and the impact of the COVID-19 pandemic thereon;

•

the impact of any protracted decline in the liquidity of credit markets on our business and the impact of the COVID-19 pandemic thereon;

•

the ability of our portfolio companies to achieve their objectives, including as a result of the current COVID-19 pandemic;

•

the valuation of our investments in portfolio companies, particularly those having no liquid trading market, and the impact of the COVID-19 pandemic thereon;

•

market conditions and our ability to access alternative debt markets and additional debt and equity capital, and the impact of the COVID-19 pandemic thereon;

•

our expected financings and investments;

•

the adequacy of our cash resources and working capital;

•

the timing of cash flows, if any, from the operations of our portfolio companies and the impact of the COVID-19 pandemic thereon; and

•

the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments and the impacts of the COVID-19 pandemic thereon.

•

changes in the political conditions and relations between the United States, Russia, Ukraine and other nations.

These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

•

an economic downturn, including as a result of the current COVID-19 pandemic, could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;

•

a contraction of available credit and/or an inability to access the equity markets, including as a result of the current COVID-19 pandemic, could impair our lending and investment activities;

•

interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;

•

currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars; and

•

the risks, uncertainties and other factors we identify in Item 1A. — Risk Factors contained in our Annual Report on Form 10-K for the year ended December 31, 2021, elsewhere in this Quarterly Report on Form 10-Q and in our other filings with the SEC.

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in the section entitled “Item 1A. Risk Factors” and elsewhere in this report. These forward-looking statements apply only as of the date of this report. Moreover, we assume no duty and do not undertake to update the forward-looking statements.

The following analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the related notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.

Overview

The Company was formed as a limited liability company under the laws of the State of Delaware on May 18, 2018. We have elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and have elected to be treated as a regulated investment company (“RIC”) for U.S. federal income tax purposes. As such, we are required to comply with various regulatory requirements, such as the requirement to invest at least 70% of our assets in “qualifying assets,” source of income limitations, RIC asset diversification requirements, and the requirement to distribute annually at least 90% of our taxable income and tax-exempt interest. In addition, we expect that all of the Company’s total portfolio will be comprised of investments in the U.S.

SLR Capital Partners, LLC (the “Adviser”) serves as the Company’s investment adviser pursuant to an investment management agreement between the Company and the Adviser (as amended, restated or otherwise modified from time to time, the “Investment Management Agreement”). Subject to the overall supervision of the Company’s Board of Directors (the “Board”), the Adviser is responsible for managing the Company’s business and activities, including sourcing investment opportunities, conducting research, performing diligence on potential investments, structuring our investments, and monitoring our portfolio companies on an ongoing basis through a team of investment professionals. The managing members of the Adviser are Michael Gross and Bruce Spohler, who also comprise the Adviser’s investment committee. Pursuant to the Investment Management Agreement, the Adviser has also been appointed to provide administrative and coordination services to the Company (in such capacity, the “Administrative Coordinator”). The Administrative Coordinator supervises or provides the Company’s administrative services, including operational trade support, net asset value calculations, financial reporting, fund accounting, registrar and transfer agent services. The Administrative Coordinator also provides assistance to the Adviser in connection with communicating with investors and other persons with respect to the Company.

The Company is organized primarily for investors who may invest through one or more investment funds created by one or more financial institutions unaffiliated with the Company (collectively, the “Access Fund”). Certain other investors may also invest directly in the Company. For those investors who invest through the Access Fund, we expect the Access Fund will issue a pro rata interest to each investor in the Access Fund (the “Access Fund Investors”) that, with respect to each Access Fund Investor’s investment in the Access Fund, corresponds to the pro rata share of the units issued by the Company to the Access Fund. We also expect that units will only be sold (i) in the U.S. only to U.S. persons who are “accredited investors” within the meaning of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”) and (ii) outside the U.S. in accordance with Regulation S under the Securities Act. Upon a sale of units to an investor, we expect the Access Fund will pass its voting rights in the Company through to the Access Fund Investors.

The Company’s principal focus is to invest in first lien secured floating rate loans primarily to upper middle market private leveraged companies (generally, loan sizes of $100 million to $300 million to companies with earnings before interest, tax, depreciation and amortization (“EBITDA”) between approximately $25 million and $100 million) that have significant free cash flow and are in non-cyclical industries in which the Adviser has direct experience. In addition to senior secured loans to upper middle market companies, the Company intends to invest a portion of its

assets in non-traditional asset-based loans and first lien loans to rapidly growing healthcare companies. The Company also expects that some of its investments will contain delayed-draw term loan type features (which is a legally binding commitment by the Company to fund additional term loans to a borrower in the future) and/or other types of unfunded commitments. The Company will seek to be the single source lender for the majority of its portfolio companies by leveraging the significant capital base at the Adviser for co-investment opportunities where appropriate. The Company believes many financial sponsors and individual corporate management teams are looking for a single lender to provide the entire debt financing to streamline and simplify the debt negotiation process. In order to provide a single source lender while maintaining the Company’s investment objectives, the Company expects to co-invest with other vehicles managed by the Adviser. There can be no assurance that the Company will be able to co-invest with such other funds, including as a result of legal restrictions and contractual restrictions and, as a result, the Company may not be able to meet its investment objective. The Company believes the potential scale resulting from co-investments with vehicles managed by the Adviser will provide the Company a significant advantage to source loans over other lenders that do not have the capital base to provide the entire debt financing.

The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and the Company may from time to time take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act.

Recent Developments

None.

Revenues

The Company’s principal focus is to invest in first lien secured floating rate loans primarily to upper middle market private leveraged companies (generally, loan sizes of $100 million to $300 million to companies with EBITDA between approximately $25 million and $100 million) that have significant free cash flow and are in non-cyclical industries in which we have direct experience. In addition to senior secured loans to upper middle market companies, the Company intends to invest a portion of its assets in non-traditional asset-based loans and first lien loans to rapidly growing healthcare companies.

Expenses

The Company will (directly or indirectly) bear:

(i)

all of its fees, costs, expenses and liabilities, all of its investment-related fees, costs, expenses and liabilities (including with respect to amounts incurred prior to the Company’s initial closing) and all of its other operating fees, costs, expenses and liabilities, including all fees, due diligence costs and other fees, costs, expenses and liabilities related to the identification, sourcing, evaluation, pursuit, acquisition, holding, appraisals, asset management, restructuring and disposing of investments, including all reasonable travel-related fees, costs, expenses and liabilities, including lodging and meals, all fees, costs, expenses and liabilities of legal counsel and financial and other advisers incurred in connection therewith, all fees, costs, expenses and liabilities of information technology services relating to the ongoing management of investments, and all other investment-related fees, costs, expenses and liabilities (to the extent not reimbursed by the relevant portfolio company);

(ii)

all fees, costs, expenses and liabilities related to any audits or agreed upon procedures, tax forms and return preparations and filings, custodian fees and expenses, fund accounting, administrator services, financial statement preparation and reporting, web services for the benefit of Unitholders, delivery costs and expenses in connection with reporting obligations and communications and compliance services;

(iii)

all fees, costs, expenses and liabilities relating to insurance policies (including director and officer liability insurance) maintained by or for the Company, including in respect of Portfolio Investments and/or personnel of the Adviser, the Administrative Coordinator and their affiliates;

(iv)

other administrative fees, costs, and liabilities;

(v)

all fees, costs, expenses and liabilities of brokers, transaction finders and other intermediaries, including brokerage commissions and spreads, and all other transaction-related fees, costs, expenses and liabilities, including reverse break-up fees;

(vi)

all fees, costs, expenses and liabilities relating to derivatives and hedging transactions;

(vii)

all principal amounts of, and interest expense on, borrowings and guarantees, and all other fees, costs, expenses and liabilities arising out of borrowings and guarantees, including the arranging and maintenance thereof, whether incurred by the Company or incurred or facilitated by a special purpose vehicle that makes Portfolio Investments;

(viii)

Management Fees;

(ix)

Administration Fees;

(x)

all fees, costs, expenses and liabilities incurred through the use or engagement of Service Providers;

(xi)

all taxes, fees, penalties and other governmental charges levied against the Company and all fees, costs, expenses, penalties and liabilities related to tax compliance;

(xii)

all fees, costs, expenses and liabilities of the Company’s legal counsel related to extraordinary matters, including expenses for any dispute resolution (including litigation and regulatory-related legal expenses);

(xiii)

all fees, costs, expenses and liabilities relating to legal and regulatory filings, including securities law filings relating to Portfolio Investments;

(xiv)

all fees, costs, expenses and liabilities related to the Company’s indemnification or contribution obligations;

(xv)

all fees, costs, expenses and liabilities for subscription services (to the extent such subscription is required by the general partner of the Access Fund);

(xvi)

any required regulatory filings and related legal fees;

(xvii)

all fees, costs, expenses and liabilities of liquidating the Company;

(xviii)

transfer agent services; and

(xix)

any other fees, costs, expenses and liabilities not specifically assumed by the Adviser or the Administrative Coordinator.

In addition, the aggregate amount of the operating expenses relating to Unitholders investing directly in the Company set forth in clauses (ii)-(iv) and the operating expenses included in sub-clauses (xiii) and (xvi) related to U.S. regulatory bodies above borne by the Company (directly or indirectly) will not exceed the Operating Expense Cap, calculated as follows: (A) if the Company has less than or equal to $400 million in Commitments, an amount equal to the sum of (x) the product of the Commitments and 0.0025 and (y) $1.25 million, or (B) if the Company has greater than $400 million in Commitments, $2.25 million. Any amount in excess of the Operating Expense Cap for any fiscal year will be paid by the Adviser. Solely by way of example, if Commitments equal $350 million, the Operating Expense Cap will be equal to $2.125 million. For the avoidance of doubt, the Operating Expense Cap will not apply to any fees, costs, expenses and liabilities allocable to persons investing indirectly in the Company through any Unitholder.

Additionally, the Company will not bear the costs of any third-party valuation agent engaged solely for purposes of valuing the net asset value of the Company.

expenses, incurred in connection with the initial offering of Units and the formation and establishment of the Company. The Adviser or Administrative Coordinator (or such affiliate) has been reimbursed by the Company for such advanced costs and expenses in an amount not to exceed $0.5 million. Accordingly, $0.3 million of offering expenses were charged to capital and $0.1 million of organizational costs were expensed in 2019.

Portfolio and Investment Activity

During the three months ended March 31, 2022, we invested $40.5 million across 22 portfolio companies. This compares to investing $50.3 million in 10 portfolio companies for the three months ended March 31, 2021. Investments sold or prepaid during the three months ended March 31, 2022 totaled $21.5 million versus $3.8 million for the three months ended March 31, 2021.

At March 31, 2022, our portfolio consisted of 53 portfolio companies and was invested 99.9% directly in senior secured loans and 0.1% in common equity/equity interests/warrants, in each case, measured at fair value versus 32 portfolio companies invested 99.9% directly in senior secured loans and 0.1% in common equity/equity interests/warrants at March 31, 2021.

At March 31, 2022, 96.8% of our income producing investment portfolio was floating rate and 3.2% was fixed rate, measured at fair value. At March 31, 2021, 98.6% of our income producing investment portfolio was floating rate and 1.4% was fixed rate, measured at fair value.

Critical Accounting Policies

The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.

Valuation of Portfolio Investments

The Company’s NAV will be calculated periodically by the Adviser or its delegate, and approved by the Board, by taking the value of the Portfolio Investments and other assets of the Company and subtracting all liabilities, including accrued expenses.

It is anticipated that in respect of many of the Company’s assets, readily available market quotations will not be obtainable and that such assets will be valued at fair value.

For purposes of calculating the NAV, the Company’s assets will generally be valued as described in Note 2(b) to the Company’s Consolidated Financial Statements.

Leverage

The Company is required to comply with the asset coverage requirements of the 1940 Act. The Company expects to employ leverage and otherwise incur indebtedness with respect to the portfolio both on a recourse and non-recourse basis (including and potentially through guarantees, derivatives, forward commitments and reverse repurchase agreements), but will not exceed the maximum amount permitted by the 1940 Act. The Company is generally permitted, under specified conditions, to issue senior securities in amounts such that the Company’s asset coverage, as defined in the 1940 Act, is at least equal to 150% immediately after such issuance. In connection with the organization of the Company, the Adviser, as the initial Unitholder, has authorized the Company to adopt the 150%

asset coverage ratio as of August 2, 2018. In connection with their subscriptions of the Units, our Unitholders were required to acknowledge our ability to operate with an asset coverage ratio that may be as low as 150%. The Company will be exposed to the risks of leverage, which may be considered a speculative investment technique. The use of leverage magnifies the potential for gain and loss on amounts invested and therefore increases the risks associated with investing in our securities. In addition, the costs associated with our borrowings, including any increase in the management fee payable to the Adviser will be borne by our Unitholders. As of March 31, 2022, the Company held $287.1 million of senior securities, for an asset coverage ratio of 163.0%.

Taxation as a Regulated Investment Company (“RIC”)

The Company elected to be treated as a RIC under Subchapter M of the Code and intends to qualify for taxation as a RIC annually. As a RIC, the Company generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it timely distributes to Unitholders as dividends. In order to qualify for taxation as a RIC, the Company is required, among other things, to be diversified at each quarter end and to timely distribute to its Unitholders at least 90% of investment company taxable income, as defined by the Code, for each year. There is no guarantee the Company will be able to maintain its status as a RIC. Depending on the level of taxable income earned in a given tax year, the Company may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company will accrue an estimated excise tax, if any, on estimated excess taxable income.

Recent Accounting Pronouncements

Results of Operations

Results are shown for the three months ended March 31, 2022 and March 31, 2021:

Investment Income

For the three months ended March 31, 2022 and March 31, 2021, gross investment income totaled $8.6 million and $3.3 million, respectively. The comparative increase in gross investment income is due to a substantial increase in the size of the income-producing portfolio.

Expenses

Expenses totaled $4.6 million and $1.9 million, respectively, for the three months ended March 31, 2022 and March 31, 2021, of which $1.8 million and $0.7 million, respectively, were management, incentive and administration fees and $2.6 million and $1.0 million, respectively, were interest and other credit facility expenses. Administrative services, organization and other general and administrative expenses totaled $0.2 million and $0.2 million, respectively, for the three months ended March 31, 2022 and March 31, 2021. Expenses generally consist of management fees, administration fees, performance-based incentive fees, insurance, legal expenses, directors’ expenses, audit and tax expenses and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The comparative increase in expenses is due to a substantial increase in the size of the portfolio.

Net Investment Income

The Company’s net investment income totaled $4.0 million and $1.5 million, or $0.24 and $0.15 per average unit, respectively, for the three months ended March 31, 2022 and March 31, 2021.

Net Realized Gain (Loss)

The Company had investment sales and prepayments totaling approximately $21.5 million and $3.8 million, respectively, for the three months ended March 31, 2022 and March 31, 2021. Net realized gain (loss) over the same periods totaled $0 and ($0.01) million, respectively.

Net Change in Unrealized Gain

For the three months ended March 31, 2022 and March 31, 2021, net change in unrealized gain on the Company’s assets totaled $0.8 million and $0.5 million, respectively. Net unrealized gain for the three months ended March 31, 2022 was primarily due to appreciation on our investments in SOC Telemed, Inc., Cerapedics, Inc. and Apex Service Partners, LLC, among others, partially offset by depreciation on our investments in High Street Buyer, Inc. and Enverus Holdings, Inc., among others, as well as the reversal of previously recognized appreciation in Community Brands ParentCo, LLC. Net unrealized gain for the three months ended March 31, 2021 was primarily due to appreciation on our investments in Enverus Holdings, Inc., Senseonics Holdings, Inc. and World Insurance Associates, LLC, among others, partially offset by depreciation on our investments in Galway Partners Holdings, LLC, among others.

Net Increase in Unitholders’ Capital Resulting From Operations

For the three months ended March 31, 2022 and March 31, 2021, the Company had a net increase in Unitholders’ capital resulting from operations of $4.8 million and $1.9 million, respectively. For the same period, income per average unit were $0.28 and $0.20, respectively.

Financial Condition, Liquidity and Capital Resources

Our primary uses of cash are for (i) investments in portfolio companies and other investments to comply with certain portfolio diversification requirements, (ii) the cost of operations (including paying the Adviser), (iii) debt service of any borrowings, and (iv) cash distributions to our Unitholders.

Equity

During the period March 12, 2019 (commencement of operations) to March 31, 2022, on a net basis, the Company sold and issued 17,137,275 common units at an average price of $10.30 per unit, for net proceeds of $176.5 million. All of our outstanding units were issued and sold in reliance upon the available exemptions from registration requirements of Section 4(a)(2) of the Securities Act. Unfunded equity capital commitments totaled $149.5 million at March 31, 2022.

Debt

Revolving credit facility due December 2023 (the “SPV Facility”)—On February 27, 2019, the Company, through its wholly-owned subsidiary, SCP Private Credit Income BDC SPV LLC (the “SPV”), entered into a $100 million SPV Facility with JPMorgan Chase Bank, N.A. acting as administrative agent. The commitment can also be expanded up to $400 million. The stated interest rate on the SPV Facility is LIBOR plus 2.75% with no LIBOR floor requirement and the current final maturity date is December 31, 2023. The fee on undrawn commitments is generally 0.875%. The SPV Facility is secured by all of the assets held by SPV. Under the terms of the SPV Facility, the Company and SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV also includes usual and customary events of default for credit facilities of this nature. On November

18, 2019, the Company amended the SPV Facility, reducing commitments to $75 million. On February 27, 2021, the Company again amended the SPV Facility, increasing commitments to $100 million. On July 16, 2021, the Company entered into an amended and restated SPV Facility, which increased commitments to $125 million, and on August 18, 2021 entered into a second amended and restated SPV Facility which increased commitments to $200 million and extended the final maturity date to December 31, 2023. On November 2, 2021, the Company entered into Amendment No. 1 to the second amended SPV Facility, which increased commitments to $275 million. As of March 31, 2022, there were $228.1 million of borrowings outstanding under the SPV Facility.

Revolving credit facility due December 2022 (the “Subscription Facility”)—During the first quarter of 2019, the Company established the $35.0 million Subscription Facility with East West Bank, and subsequently entered into an amendment on June 24, 2019, which increased commitments from $35.0 million to $50.0 million. On March 5, 2021, the Company entered into a second amendment. Under the second amendment, commitments were increased from $50.0 million to $75.0 million, the stated interest rate on the Subscription Facility is LIBOR plus 2.70% and the maturity date was extended. On October 4, 2021, the Company entered into an amended and restated loan and security agreement, which increased commitments to $100 million and extended the maturity date to December 31, 2022. Under the terms of the Subscription Facility, the Company has made certain customary representations and warranties, and is required to comply with various covenants, including reporting requirements and other customary requirements for similar credit facilities. The Subscription Facility also includes usual and customary events of default for credit facilities of this nature. As of March 31, 2022, there were $59.0 million of borrowings outstanding under the Subscription Facility.

Cash Equivalents

We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time-to-time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on our credit facilities, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held no cash equivalents at March 31, 2022.

Contractual Obligations

We have entered into certain contracts under which we have material future commitments. We have entered into the Investment Management Agreement with the Adviser in accordance with the 1940 Act. Under the Investment Management Agreement, the Company will pay the Adviser the Management Fee and the Incentive Fee, and the Administrative Coordinator the Administration Fee. Under the Investment Management Agreement, the Administrative Coordinator may engage or delegate certain administrative functions to third parties or affiliates on behalf of the Company. The Administrative Coordinator will be responsible for all expenses of its own staff responsible for (i) certain on-going, routine, non-investment-related administrative services for the Company, (ii) the coordination of various third party services needed or required by the Company, and (iii) certain Unitholder servicing functions.


	Payments due by Period as of March 31, 2022 (dollars in millions)
	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Credit facilities (1)	$	287.1	$	59.0	$	228.1	$	—	$	—

(1)	At March 31, 2022, we had a total of $87.9 million of unused borrowing capacity under our credit facilities, subject to borrowing base limits.

If any of the contractual obligations discussed above are terminated, our costs under any new agreements that we enter into may increase. In addition, we would likely incur significant time and expense in locating alternative parties to provide the services we expect to receive under the Investment Management Agreement. Any new investment advisory agreement would also be subject to approval by our Unitholders.

Off-Balance Sheet Arrangements

From time-to-time and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loan or equity commitments. These unfunded capital commitments always take into account the Company’s liquidity and cash available for investment, portfolio and issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at March 31, 2022 and December 31, 2021, respectively:


	March 31, 2022		December 31, 2021
*(in millions)*
Arcutis Biotherapeutics, Inc.	$	18.4	$	18.4
BridgeBio Pharma, Inc.		9.8		9.8
CC SAG Holdings Corp. (Spectrum Automotive)		7.9		8.0
Vessco Midco Holdings, LLC		5.8		5.9
NAC Holdings Corporation		5.8		6.5
Glooko, Inc.		5.3		5.3
Inszone Mid, LLC		4.5		5.3
High Street Buyer, Inc.		4.3		1.1
Maurices, Incorporated		3.7		5.0
Transportation Insight, LLC		3.7		3.8
Vapotherm, Inc.		3.0		—
Ardelyx, Inc.		2.7		—
Ivy Fertility Services, LLC		1.9		1.9
Enverus Holdings, Inc.		1.8		1.8
GSM Acquisition Corp.		1.7		1.1
RQM+ Corp.		1.6		1.6
Erie Construction Mid-west, LLC		1.6		1.6
RxSense Holdings, LLC		1.6		1.6
Nexus Intermediate III, LLC (Vortex)		1.3		1.3
Basic Fun, Inc.		1.2		0.9
Kid Distro Holdings, LLC		1.1		1.1
Plastics Management, LLC		1.0		4.5
MMIT Holdings, LLC		1.0		0.8


	March 31, 2022		December 31, 2021
Foundation Consumer Brands, LLC		1.0		1.0
SOC Telemed, Inc.		0.9		0.9
MRI Software LLC		0.9		2.2
Tilley Chemical Buyer, Inc.		0.7		2.9
Apex Service Partners, LLC		0.7		4.2
Rezolute, Inc.		0.6		1.2
BayMark Health Services, Inc.		0.6		0.9
Peter C. Foy & Associates Insurance Services, LLC		0.6		1.6
SunMed Group Holdings, LLC		0.4		0.4
World Insurance Associates, LLC		0.4		0.3
Pinnacle Treatment Centers, Inc.		0.3		0.6
Ultimate Baked Goods Midco LLC		0.2		0.3
All States Ag Parts, LLC		0.2		0.3
TAUC Management, LLC		0.1		1.5
Neuronetics, Inc.		—		0.4
ENS Holdings III Corp. & ES Opco USA LLC		—		0.3

Total Commitments	$	98.3	$	106.3

Distributions

Tax characteristics of all distributions will be reported to unitholders on Form 1099 after the end of the calendar year. Future quarterly distributions, if any, will be determined by the Board. We expect that our distributions to unitholders will generally be from accumulated net investment income, from net realized capital gains or non-taxable return of capital, if any, as applicable.

We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (i.e., net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, our revolving credit facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual

payment-in-kind income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.

With respect to the distributions to unitholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to unitholders.

Related Parties

We have entered into the Investment Management Agreement with the Adviser. Mr. Gross, our Chairman, Co-Chief Executive Officer and President and Mr. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Adviser. In addition, Mr. Peteka, our Chief Financial Officer, Treasurer and Secretary serves as the Chief Financial Officer for the Adviser.

The Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Adviser presently serves as investment adviser to SLR Investment Corp., a publicly traded BDC, which focuses on investing in senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities as well as SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry. In addition, Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SLR Investment Corp. and SLR HC BDC LLC. The Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Adviser or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Adviser’s allocation procedures. On June 13, 2017, the Adviser received an exemptive order that permits the Company to participate in negotiated co-investment transactions with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Order”). If the Company is unable to rely on the Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its Unitholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Adviser.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

We are subject to financial market risks, including changes in interest rates. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic, which has resulted in an increase in the level of volatility across such markets and a general decline in value of the securities that we hold. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. In a prolonged low interest rate environment, including a reduction of LIBOR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense

incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such difference could potentially increase thereby increasing our net investment income. During the three months ended March 31, 2022, certain investments in our investment portfolio had floating interest rates. These floating rate investments were primarily based on floating LIBOR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have LIBOR floors. The Company also has revolving credit facilities that are generally based on floating LIBOR. Assuming no changes to our balance sheet as of March 31, 2022 and no new defaults by portfolio companies, a hypothetical one percent decrease in LIBOR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately twelve cents per average share over the next twelve months. Assuming no changes to our balance sheet as of March 31, 2022 and no new defaults by portfolio companies, a hypothetical one percent increase in LIBOR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately one cent per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time-to-time by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At March 31, 2022, we have no interest rate hedging instruments outstanding on our balance sheet.


Increase (Decrease) in LIBOR		(1.00	%)		1.00	%
Increase in Net Investment Income Per Unit Per Year	$	0.12		$	0.01

Item 4.

Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

As of March 31, 2022 (the end of the period covered by this report), our management, including our Co-Chief Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the 1934 Act). Based on that evaluation, our management, including the Co-Chief Executive Officers and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Co-Chief Executive Officers and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

(b) Changes in Internal Controls Over Financial Reporting

Management has not identified any change in the Company’s internal control over financial reporting that occurred during the first quarter of 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

We and the Adviser are not currently subject to any material pending legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings incidental to the normal course of our business including the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our business, financial condition or results of operations beyond what has been disclosed within these financial statements.

Item 1A.

Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the March 1, 2022 filing of the Annual Report on Form 10-K, which could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factor set forth below, there have been no material changes during the three months ended March 31, 2022 to the risk factors discussed in “Risk Factors” in the March 1, 2022 filing of our Annual Report on Form 10-K.

The Russian invasion of Ukraine may have a material adverse impact on us and our portfolio companies.

On February 24, 2022, the Russian military commenced a full-scale invasion of Russia’s pre-positioned forces into Ukraine, which could have a negative impact on the economy and business activity globally (including in the countries in which the Company invests), and therefore could adversely affect the performance of the Company’s investments. Following such invasion, the United States and several European nations announced sanctions against Russia. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to the Company and the performance of its investments or operations, and the ability of the Company to achieve its investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

There were no unregistered sales of equity securities other than those already disclosed in certain Form 8-Ks filed with the SEC.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosure

Not applicable.

Item 5.

Other Information

Not applicable.

Item 6.

Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:


3.1		Certificate of Formation⁽¹⁾

3.2		Second Amended and Restated Limited Liability Company Agreement⁽²⁾

4.1		Form of Subscription Agreement⁽¹⁾

31.1		Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*

31.2		Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*

31.3		Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*

32.1		Certification of Co-Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

32.2		Certification of Co-Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

32.3		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

*	Filed herewith.

(1)	Previously filed as an exhibit to Amendment No. 1 to the Registrant’s Registration Statement on Form 10 (File No. 000-55955) filed with the SEC on August 24, 2018.

(2)	Previously filed in connection with the Registrant’s report on Form 10-K filed on February 20, 2020.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on May 3, 2022.


SCP PRIVATE CREDIT INCOME BDC LLC

By:		/s/ MICHAEL S. GROSS
		Michael S. Gross
		Co-Chief Executive Officer
		(Principal Executive Officer)

By:		/s/ BRUCE J. SPOHLER
		Bruce J. Spohler
		Co-Chief Executive Officer
		(Principal Executive Officer)

By:		/s/ RICHARD L. PETEKA
		Richard L. Peteka
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller Reporting company

Emerging growth company